The CRO concept continued to be strong, with Baihua Pharmaceutical rising more than 10% in a row, and Kangming Kangde, Gloria Ying, Zhaoyan New Pharmaceutical, Kanglong Chemical, and Innox followed suit.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.